Zobrazeno 1 - 10
of 447
pro vyhledávání: '"Soukop, M."'
Publikováno v:
BMJ: British Medical Journal, 1997 Mar . 314(7084), 869-869.
Externí odkaz:
https://www.jstor.org/stable/25174054
Autor:
Evans, T.R.J. *, Pentheroudakis, G., Paul, J., McInnes, A., Blackie, R., Raby, N., Morrison, R., Fullarton, G.M., Soukop, M., McDonald, A.C.
Publikováno v:
In Annals of Oncology September 2002 13(9):1469-1478
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mackay, H.J. *, McInnes, A., Paul, J., Raby, N., Lofts, F.J., McDonald, A.C., Soukop, M., Fullarton, G.M., Harris, A.L., Garcia-Vargas, J., Evans, T.R.J.
Publikováno v:
In Annals of Oncology October 2001 12(10):1407-1410
Autor:
de Bono, J.S. *, Fraser, J.A., Lee, F., Simpson, A., Lim, C., Naik, S., Soukop, M., Dunlop, D.J.
Publikováno v:
In Annals of Oncology June 2000 11(6):749-752
Publikováno v:
The British Medical Journal, 1978 Feb . 1(6111), 493-494.
Externí odkaz:
https://www.jstor.org/stable/20417976
Publikováno v:
The British Medical Journal, 1978 May . 1(6124), 1422-1422.
Externí odkaz:
https://www.jstor.org/stable/20419199
Autor:
Allan, S. G., Bayliss, E. J., Warrington, P. S., Leonard, R. C. F., Cunningham, D., Soukop, M.
Publikováno v:
British Medical Journal (Clinical Research Edition), 1985 Apr . 290(6476), 1212-1213.
Externí odkaz:
https://www.jstor.org/stable/29518975
Autor:
Eatock, M M, Anthony, D A, El-Abassi, M, Wilson, P, Paul, J, Smith, M, Soukop, M, Evans, T R J
Publikováno v:
British Journal of Cancer
The standard treatment for advanced gastro-oesophageal cancer in the UK is epirubicin, cisplatin and continuous infusion 5-fluoruracil by an indwelling central venous catheter (ECF), which has significant morbidity. Raltitrexed (tomudex), a specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::392e20802df0cf1aee1541f2feabdaf5
http://europepmc.org/articles/PMC2363246
http://europepmc.org/articles/PMC2363246
Autor:
Clamp, A.R., Blackhall, F., Vasey, P., Soukop, M., Coleman, R., Halbert, G., Robson, L., Jayson, G.C., Canc Res UK Phase I II Comm
Bryostatin-1 is a macrocyclic lactone whose main mechanism of action is protein kinase C modulation. We investigated its activity as a weekly 24-h infusion in recurrent ovarian carcinoma. In all, 17 patients were recruited and 11 had chemotherapy-res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::bc00457d7d1ebf5cc7fbdc22e58fb5e6
